2 Growth Stocks Set to Skyrocket in 2025 and Beyond
2 Growth Stocks Set to Skyrocket in 2025 and Beyond
If you're looking for two growth stocks that could soar in 2025 and beyond, Calian Group (TSX:CGY) and Lumine Group (TSXV:LMN) are compelling picks. Both growth stocks have strong fundamentals, exciting growth potential, and unique niches in thriving industries. Let's dive into why these growth stocks deserve a spot on your watchlist.
如果你正在尋找兩隻可能在2025年及以後飆升的成長型股票,那麼加聯集團(多倫多證券交易所股票代碼:CGY)和Lumine集團(多倫多證券交易所股票代碼:LMN)是引人注目的選擇。這兩隻成長型股票都具有強勁的基本面,令人興奮的增長潛力,並在蓬勃發展的行業中佔有獨特的利基市場。讓我們深入探討爲什麼這些成長型股票值得在您的關注清單上佔有一席之地。
Calian stock
加里安股票
Calian Group, headquartered in Ottawa, is a diversified company providing services ranging from healthcare to cybersecurity and advanced technology. It's like that overachieving kid in class who's not just great at one subject but excels across the board.
總部位於渥太華的Calian Group是一家多元化公司,提供從醫療保健、網絡安全和先進技術等各種服務。就像課堂上那個成績超群的孩子,他不僅擅長一門科目,而且全面表現出色。
The growth stock's revenue for the trailing 12 months reached $741.39 million, reflecting an impressive 11.1% year-over-year growth. Despite a dip in quarterly earnings, Calian is a long-term play, supported by a robust operating cash flow of $90.51 million and a manageable debt-to-equity ratio of 39.88%. With a forward price-to-earnings (P/E) ratio of just 10.13, the stock seems undervalued, considering its diversification and growth trajectory.
該成長型股票在過去12個月中的收入達到7.4139億美元,同比增長了11.1%,令人印象深刻。儘管季度收益有所下降,但Calian是一家長期公司,由9,051萬美元的強勁運營現金流和39.88%的可控債務與權益比率提供支持。該股的遠期市盈率(P/E)僅爲10.13,考慮到其多元化和增長軌跡,其估值似乎被低估了。
What sets Calian apart is its ability to pivot and adapt. The growth stock has steadily built a reputation for acquiring complementary businesses, which has helped it diversify its revenue streams. Over the past year, its market cap has hovered around $590.59 million, showcasing resilience even amid market volatility. For investors eyeing dividends, Calian recently announced an annual dividend yield of 2.33%, a cherry on top for growth-oriented portfolios.
Calian的與衆不同之處在於其調整和適應能力。成長型股票在收購互補業務方面穩步樹立了聲譽,這有助於其實現收入來源的多元化。在過去的一年中,其市值一直徘徊在5.9059億美元左右,即使在市場波動的情況下也表現出彈性。對於關注分紅的投資者來說,Calian最近宣佈的年股息收益率爲2.33%,對於以增長爲導向的投資組合來說,這是一顆櫻桃。
Lumine
Lumine
Lumine Group is a rising star in the vertical market software industry. Think of it as a savvy investor who buys under-appreciated software businesses and transforms them into winners. Lumine's strategy mirrors that of its parent company, Constellation Software, which has already proven that this model works wonders. Over the past year, Lumine's quarterly revenue growth shot up by 35.1%, reaching $624.36 million in the trailing 12 months. The growth stock also maintains a healthy current ratio of 1.96, signalling strong liquidity.
Lumine集團是垂直市場軟件行業的後起之秀。可以把它想象成一個精明的投資者,他收購了被低估的軟件企業,並將其轉變爲贏家。Lumine的戰略反映了其母公司Constellation Software的戰略,後者已經證明這種模式可以創造奇蹟。在過去的一年中,Lumine的季度收入增長了35.1%,在過去的12個月中達到6.2436億美元。成長存量也保持健康 當前比率 爲1.96,表明流動性強。
Despite being relatively new to the scene, Lumine's stock price has surged by 86.22% over the past year, indicating investor confidence. Its market cap now sits at a hefty $11.75 billion, and with a forward P/E ratio of 41.67, the stock is trading at a premium, but for good reason. Lumine has the potential to dominate its niche market. It is supported by an aggressive acquisition strategy and a dedicated management team. For long-term investors, it's a bet on the continued digital transformation across industries.
儘管相對較新,但Lumine的股價在過去一年中飆升了86.22%,這表明了投資者的信心。其市值目前高達117.5億美元,遠期市盈率爲41.67,股價溢價,但這是有充分理由的。Lumine有可能主導其利基市場。它得到了積極的收購策略和專門的管理團隊的支持。對於長期投資者來說,這是對各行各業持續數字化轉型的押注。
Future focus
未來的重點
Looking ahead, both Calian and Lumine have bright futures. Calian's focus on cybersecurity and healthcare aligns with two of the fastest-growing sectors globally. The increasing demand for robust security solutions and the aging population's healthcare needs provide Calian with tailwinds that are hard to ignore. Lumine, however, benefits from the digitization of traditional industries. Its portfolio companies cater to essential sectors like communications and media, making it a solid play for the tech-savvy investor.
展望未來,Calian和Lumine都有光明的未來。Calian對網絡安全和醫療保健的關注與全球增長最快的兩個行業一致。對強大安全解決方案的需求不斷增加,人口老齡化的醫療保健需求爲Calian提供了不容忽視的利好因素。但是,Lumine受益於傳統行業的數字化。其投資組合公司迎合了通信和媒體等重要領域,這使其成爲精通科技的投資者的不二之選。
Past performance is another reason to believe in these companies. Calian's disciplined approach to growth has led to steady returns for shareholders, with a beta of 0.89, signalling lower volatility. Lumine's meteoric rise since its public debut reflects its ability to execute its acquisition-focused strategy with precision.
過去的表現是相信這些公司的另一個原因。Calian嚴格的增長方針爲股東帶來了穩定的回報,beta值爲0.89,表明波動性降低。Lumine自公開上市以來的飛速崛起反映了其精確執行以收購爲重點的戰略的能力。
Both growth stocks are set to benefit from their strong financials and visionary leadership. While Calian leverages its diverse offerings to hedge against market risks, Lumine focuses on dominating a specific niche with razor-sharp precision. These approaches make them complementary additions to any growth-focused portfolio.
這兩隻成長型股票都將受益於其強勁的財務狀況和遠見卓識的領導力。儘管Calian利用其多樣化的產品來對沖市場風險,但Lumine專注於以極高的精度主導特定的利基市場。這些方法使它們成爲任何以增長爲重點的投資組合的補充。
Bottom line
底線
As with any investment, risks remain. For Calian, geopolitical tensions could impact its government contracts, while Lumine's growth depends heavily on successful acquisitions. However, the strong balance sheets and proven business models mitigate these risks.
與任何投資一樣,風險仍然存在。對於Calian來說,地緣政治緊張局勢可能會影響其政府合同,而Lumine的增長在很大程度上取決於成功的收購。但是,強勁的資產負債表和成熟的商業模式可以緩解這些風險。
So, whether you prefer Calian's stable, diversified growth or Lumine's high-octane tech play, both stocks are poised to make waves in 2025 and beyond. If you're in it for the long haul, these companies could be the growth engines your portfolio needs.
因此,無論你更喜歡Calian的穩定、多元化增長,還是Lumine的高辛烷值科技股票,這兩隻股票都有望在2025年及以後掀起波瀾。如果你長期參與其中,這些公司可能會成爲你的投資組合所需的增長引擎。
譯文內容由第三人軟體翻譯。